Andrey Golubev

NewVac LLC is a holding company, which engages in the development of cancer therapy methods. The firm focuses in the investigation of the effectiveness and development of therapeutic vaccines and new indications registered as immunotherapeutic methods in oncology. It also specializes in personalized medicine, combination of cancer therapy, and GMP production of vaccines and cellular products. The company was founded in 2010 and is headquartered in Khimki, Russia.

NewVac LLC is a holding company, which engages in the development of cancer therapy methods. The firm focuses in the investigation of the effectiveness and development of therapeutic vaccines and new indications registered as immunotherapeutic methods in oncology. It also specializes in personalized medicine, combination of cancer therapy, and GMP production of vaccines and cellular products. The company was founded in 2010 and is headquartered in Khimki, Russia.

NewVac LLC is a holding company, which engages in the development of cancer therapy methods. The firm focuses in the investigation of the effectiveness and development of therapeutic vaccines and new indications registered as immunotherapeutic methods in oncology. It also specializes in personalized medicine, combination of cancer therapy, and GMP production of vaccines and cellular products. The company was founded in 2010 and is headquartered in Khimki, Russia.

NewVac LLC is a holding company, which engages in the development of cancer therapy methods. The firm focuses in the investigation of the effectiveness and development of therapeutic vaccines and new indications registered as immunotherapeutic methods in oncology. It also specializes in personalized medicine, combination of cancer therapy, and GMP production of vaccines and cellular products. The company was founded in 2010 and is headquartered in Khimki, Russia.

NewVac LLC is a holding company, which engages in the development of cancer therapy methods. The firm focuses in the investigation of the effectiveness and development of therapeutic vaccines and new indications registered as immunotherapeutic methods in oncology. It also specializes in personalized medicine, combination of cancer therapy, and GMP production of vaccines and cellular products. The company was founded in 2010 and is headquartered in Khimki, Russia.